Jason Haas
Director of Finance/CFO en SYROS PHARMACEUTICALS, INC. .
Fortuna: 434 353 $ al 31/03/2024
Perfil
Jason Haas is an Independent Director at Ligand Pharmaceuticals, Inc. and the Chief Financial Officer at Syros Pharmaceuticals, Inc. He completed his undergraduate degree at Colgate University and his MBA at Columbia Business School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 09/06/2023 | 4 145 ( 0.02% ) | 303 000 $ | 31/03/2024 | |
| 01/04/2024 | 24 552 ( 0.09% ) | 131 353 $ | 31/03/2024 |
Cargos activos de Jason Haas
| Empresas | Cargo | Inicio |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Director of Finance/CFO | 12/10/2021 |
| LIGAND PHARMACEUTICALS INCORPORATED | Director/Board Member | 29/06/2022 |
Formación de Jason Haas.
| Colgate University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Jason Haas
